Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2003
05/08/2003US20030088075 Anti-human VEGF receptor Flt-1 monoclonal antibody
05/08/2003US20030088074 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains
05/08/2003US20030088062 Polypeptide for use as an antiproliferative agent in the treatment of cell proliferative disorders
05/08/2003US20030088060 Human ion channels
05/08/2003US20030088059 Human olfactory receptors and genes encoding same
05/08/2003US20030087985 Gels for encapsulation of biological materials
05/08/2003US20030087950 New alpha-amino acid sulphonyl compounds
05/08/2003US20030087944 Such as a 1H-indole-3-glyoxylamide.
05/08/2003US20030087874 Antibiotic AA 896 analogs
05/08/2003US20030087872 Fucosidase 32616 is differentially expressed in tumor and/or angiogenic tissue samples as compared to normal tissue samples
05/08/2003US20030087871 Antisense modulation of caspase 9 expression
05/08/2003US20030087870 Method of treating fibrosis
05/08/2003US20030087868 Administration of a vector to cells in vivo comprising and expressing a transgene encoding beta-glucosidase, the vector is taken up by the cells, the transgene is expressed therein and and beta-glucosidase is produced
05/08/2003US20030087867 Administering to isolated tissue, a nucleic acid sequence delivery vehicle encoding nitric oxide synthase activity
05/08/2003US20030087866 Suppression of malignancy utilizing ribonucleotide reductase R1
05/08/2003US20030087863 Activation matrix metalloprotease; diagnosis of disease sensitivity; rheumatic diseases, bone disorders
05/08/2003US20030087862 Cancer control
05/08/2003US20030087861 Administering mixture of antibody and drug; cancer sensitivity
05/08/2003US20030087859 Therapy for vision defects, central nervous system disorders; retinal pigment epithelium; genetic engineering
05/08/2003US20030087858 Diagnostic and therapeutic compositions for alzheimer's disease
05/08/2003US20030087857 Antisense modulation of insulin-like growth factor binding protein 5 expression
05/08/2003US20030087856 Antisense modulation of IL-1 receptor-associated kinase-4 expression
05/08/2003US20030087855 Antisense modulation of protein kinase R expression
05/08/2003US20030087854 Hybrid nucleic acids; prevent, controlling gene expression
05/08/2003US20030087853 Antisense modulation of apolipoprotein B expression
05/08/2003US20030087851 Pharmaceutical composition for treating or preventing influenza, and novel oligonucleotide
05/08/2003US20030087849 Antisense modulation of HKR1 expression
05/08/2003US20030087846 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
05/08/2003US20030087845 Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation
05/08/2003US20030087837 Compositions and methods for delivery of poorly water soluble drugs and methods of treatment
05/08/2003US20030087833 Skin regeneration; antiwrinkle agents, antiaging agents
05/08/2003US20030087832 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis
05/08/2003US20030087831 1,3,4-Oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
05/08/2003US20030087830 Low molecular weight components of cartilage, complexes of metals with amino acids, DI-peptides and analogs thereof; processes for preparation and therapeutic uses thereof
05/08/2003US20030087828 Peptide derivatives and pharmaceutically acceptable salts, thereof, processes for preparation of both, and use thereof
05/08/2003US20030087827 Enzyme inhibitor; administering oligopeptides; efficient transportation of cell membrane
05/08/2003US20030087826 Conjugates comprising two active agents
05/08/2003US20030087825 Method for inhibiting the formation of seromas using factor XIII
05/08/2003US20030087823 Compositions comprising endotoxin neutralizing protein and derivatives and uses thereof
05/08/2003US20030087822 Parathyroid hormone antagonists and uses thereof
05/08/2003US20030087821 Using exendrin, or antagonist thereof; appetite control
05/08/2003US20030087820 Novel exendin agonist formulations and methods of administration thereof
05/08/2003US20030087819 Cysteine-containing peptides having antioxidant properties
05/08/2003US20030087818 Compositions and methods for the therapy and diagnosis of colon cancer
05/08/2003US20030087817 Regulation of endogenous gene expression in cells using zinc finger proteins
05/08/2003US20030087816 Anticancer, antitumor agents; genetic engineering
05/08/2003US20030087814 Synergistic mixture of enzyme inhibitor of aldehyde dehydrogenase and monoamine oxidase
05/08/2003US20030087813 Antihistamines; respiratory system disorders
05/08/2003US20030087812 Glycopeptide antibiotics
05/08/2003US20030087811 Compounds and methods for cancer therapy
05/08/2003US20030087810 Controlling gene expression in cells; anticancer agents; drug delivery
05/08/2003US20030087809 Induction apoptosis
05/08/2003US20030087807 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity
05/08/2003US20030087806 Freeze dried complex; therapy for amyotrophic lateral sclerosis, antidiabetic agents
05/08/2003US20030087804 Induction apoptosis
05/08/2003US20030087803 Insertion drugs into cells, tissue; therapy for brain disorders, central nervous system disorders
05/08/2003US20030087801 Methods for treatment using novel ligands of the neuropeptide receptor hfgan72
05/08/2003US20030087434 Process for selective expression of nucleic acid products
05/08/2003US20030087433 Activator protein for use in cell propagation and cosmetics
05/08/2003US20030087414 Mammalian mucinase, its recombinant production, and its use in therapy or prophylaxis against diseases in which mucus is involved or infectious diseases
05/08/2003US20030087412 Nucleotide sequences coding polypeptide for use in the prevention and treatment of tumors, nervous system, cardiomyopathy, viral and metabolic diseases
05/08/2003US20030087408 Protein for use in the treatment of tumors
05/08/2003US20030087407 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
05/08/2003US20030087395 Nucleotide sequences coding polypepide for use in the treatment of cardiovascular and immunological disorders
05/08/2003US20030087393 Endostatin for use in the treatment of cancer and tumor metastasis
05/08/2003US20030087391 B cell receptor associated proteins
05/08/2003US20030087387 Human toll homologues
05/08/2003US20030087386 Morphology controlling protein for use in prevention of developmental aberration
05/08/2003US20030087385 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of tumor and cell proliferation disorders
05/08/2003US20030087384 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment fibroblast growth factor receptor defects
05/08/2003US20030087379 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed
05/08/2003US20030087378 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders
05/08/2003US20030087377 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders
05/08/2003US20030087375 Sperm specific proteins
05/08/2003US20030087370 Novel nucleic acids and polypeptides
05/08/2003US20030087367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087366 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087365 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087364 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087363 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087361 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087360 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087359 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087358 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087357 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087356 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087355 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087354 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087353 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087352 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087351 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087350 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087349 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087348 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087347 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/08/2003US20030087346 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087345 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/08/2003US20030087341 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune disease
05/08/2003US20030087340 Novel human leucine-rich repeat containing protein expressed predominately in nervous system tissues, HLRRNS1
1 ... 1850 1851 1852 1853 1854 1855 1856 1857 1858 1859 1860 1861 1862 1863 1864 1865 1866 1867 1868 1869 1870 ... 3163